248 related articles for article (PubMed ID: 19073820)
1. Modern treatment of amyloidosis: unresolved questions.
Dember LM
J Am Soc Nephrol; 2009 Mar; 20(3):469-72. PubMed ID: 19073820
[TBL] [Abstract][Full Text] [Related]
2. [Treatment of amyloidosis].
Wien TN
Tidsskr Nor Laegeforen; 2008 Jun; 128(12):1397-400. PubMed ID: 18552901
[TBL] [Abstract][Full Text] [Related]
3. Heart transplantation in systemic (AL) amyloidosis: a retrospective study of eight French patients.
Mignot A; Varnous S; Redonnet M; Jaccard A; Epailly E; Vermes E; Boissonnat P; Gandjbakhch I; Herpin D; Touchard G; Bridoux F
Arch Cardiovasc Dis; 2008 Sep; 101(9):523-32. PubMed ID: 19041836
[TBL] [Abstract][Full Text] [Related]
4. Early intensification and autologous stem cell transplantation in patients with systemic AL amyloidosis: a single-centre experience.
Frossard V; Ketterer N; Rosselet A; Meier P; Cairoli A; Duchosal MA; Kovacsovics T
Ann Hematol; 2009 Jul; 88(7):681-5. PubMed ID: 19066891
[TBL] [Abstract][Full Text] [Related]
5. An overview of high-dose melphalan and stem cell transplantation in the treatment of AL amyloidosis.
Sanchorawala V; Seldin DC
Amyloid; 2007 Dec; 14(4):261-9. PubMed ID: 17968685
[TBL] [Abstract][Full Text] [Related]
6. Primary amyloidosis of the kidney.
Shafique S; Wetmore J; Almehmi A
W V Med J; 2010; 106(1):22-4. PubMed ID: 20088306
[TBL] [Abstract][Full Text] [Related]
7. Successful reduced intensity allogeneic stem cell transplantation for systemic AL amyloidosis.
Imamura T; Ogata M; Kohno K; Tomo T; Ohtsuka E; Kikuchi H; Kadota J
Am J Hematol; 2006 Apr; 81(4):281-3. PubMed ID: 16550508
[TBL] [Abstract][Full Text] [Related]
8. [Immunoglobulin light chain amyloidosis: recent molecular, clinical and therapeutic approach].
Thierry A; Bridoux F; Goodman H; Belmouaz S; Abou Ayache R; Desport E; Jaccard A; Touchard G
Nephrologie; 2004; 25(4):111-8. PubMed ID: 15291138
[TBL] [Abstract][Full Text] [Related]
9. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
Cohen AD; Zhou P; Chou J; Teruya-Feldstein J; Reich L; Hassoun H; Levine B; Filippa DA; Riedel E; Kewalramani T; Stubblefield MD; Fleisher M; Nimer S; Comenzo RL
Br J Haematol; 2007 Oct; 139(2):224-33. PubMed ID: 17897298
[TBL] [Abstract][Full Text] [Related]
10. Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
Sack FU; Kristen A; Goldschmidt H; Schnabel PA; Dengler T; Koch A; Karck M
Eur J Cardiothorac Surg; 2008 Feb; 33(2):257-62. PubMed ID: 18096396
[TBL] [Abstract][Full Text] [Related]
11. Marked shrinkage of amyloid lymphadenopathy after an intensive chemotherapy in a patient with IgM-associated AL amyloidosis.
Tazawa K; Katoh N; Shimojima Y; Matsuda M; Ikeda S
Amyloid; 2009 Dec; 16(4):243-5. PubMed ID: 19922338
[TBL] [Abstract][Full Text] [Related]
12. Amyloidosis-associated kidney disease.
Dember LM
J Am Soc Nephrol; 2006 Dec; 17(12):3458-71. PubMed ID: 17093068
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in the management of AL Amyloidosis.
Kastritis E; Dimopoulos MA
Br J Haematol; 2016 Jan; 172(2):170-86. PubMed ID: 26491974
[TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment in systemic amyloidosis].
Ikeda S
Rinsho Byori; 2008 Feb; 56(2):121-9. PubMed ID: 18404826
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of systemic amyloidosis with hepatic involvement and factor X deficiency by high dose melphalan chemotherapy and autologous stem cell reinfusion.
Breems DA; Sonneveld P; de Man RA; Leebeek FW
Eur J Haematol; 2004 Mar; 72(3):181-5. PubMed ID: 14962236
[TBL] [Abstract][Full Text] [Related]
16. [Advances in diagnosis and treatment of AL amyloidosis].
Zelichowski G; Lubas A; Wańkowicz Z
Pol Merkur Lekarski; 2008 Apr; 24(142):340-5. PubMed ID: 18634370
[TBL] [Abstract][Full Text] [Related]
17. AL amyloidosis manifesting as systemic lymphadenopathy.
Matsuda M; Gono T; Shimojima Y; Yoshida T; Katoh N; Hoshii Y; Yamada T; Ikeda S
Amyloid; 2008 Jun; 15(2):117-24. PubMed ID: 18484338
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histological responses of renal amyloidosis to high-dose melphalan supported by autologous stem cell transplantation.
Sanada S; Suzuki M; Shindo T; Suzuki S; Nakamichi T; Matsubara M; Maeda K
Nephrol Dial Transplant; 2008 Feb; 23(2):747-50. PubMed ID: 17989105
[No Abstract] [Full Text] [Related]
19. Waldenström's macroglobulinemia associated with serum amyloid A protein amyloidosis: pitfalls in diagnosis and successful treatment with melphalan-based autologous stem cell transplant.
Muzaffar J; Katragadda L; Haider S; Abdallah AO; Anaissie E; Usmani SZ
Acta Haematol; 2013; 130(3):146-9. PubMed ID: 23689541
[TBL] [Abstract][Full Text] [Related]
20. Myeloablative chemotherapy with stem cell rescue for the treatment of primary systemic amyloidosis: a status report.
Gertz MA; Lacy MQ; Dispenzieri A
Bone Marrow Transplant; 2000 Mar; 25(5):465-70. PubMed ID: 10713619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]